Saraji, Omair .

HRN: 26-54-38  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/17/2025
CEFTRIAXONE 1G (VIAL)
01/17/2025
01/24/2025
IV
600mg
OD
PCAP D
Waiting Final Action 
01/17/2025
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
01/17/2025
01/23/2025
IV
480 Mg
Q6H
PCAP D
Waiting Final Action 
01/18/2025
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
01/18/2025
01/24/2025
IV
90mg
OD
PCAP D
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: